Adam C. Labonte

941 citations
10 papers · 684 indexed · h-index 7
Topics
Systemic Lupus Erythematosus Research (6 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)Phagocytosis and Immune Regulation (2 papers)
Partner nations
United States

In The Last Decade

Adam C. Labonte

10 papers receiving 653 citations

Peers

Adam C. Labonte
Comparison fields: 5 of 87
  • Immunology 374
  • Molecular Biology 193
  • Rheumatology 189
  • Infectious Diseases 100
  • Oncology 72
Replace Hirotaka Kaneko with:
Hirotaka Kaneko Japan
Juliana E. Toller-Kawahisa Brazil
Cynthia Louis Australia
Timothy Smallie United Kingdom
Audrey Beringer France
Éric Assier France
Pam Hall Australia
Darko Stojkov Switzerland
Ziaur S. M. Rahman United States
Adam C. Labonte relative to Hirotaka Kaneko Japan Hirotaka Kaneko's profile →
Citations per field
00.5×
Hirotaka Kaneko · 1×
Citations per year

Countries citing papers authored by Adam C. Labonte

Since Specialization
Citations

This map shows the geographic impact of Adam C. Labonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam C. Labonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam C. Labonte more than expected).

Fields of papers citing papers by Adam C. Labonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam C. Labonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam C. Labonte. The network helps show where Adam C. Labonte may publish in the future.

Co-authorship network of co-authors of Adam C. Labonte

This figure shows the co-authorship network connecting the top 25 collaborators of Adam C. Labonte. A scholar is included among the top collaborators of Adam C. Labonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam C. Labonte. Adam C. Labonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 95
2 5
3 25
4 55
5 115
6 81
7 3
8 29
9 274
10
Student Voice and Sensemaking of Multiculturalism on Campus
2

About Adam C. Labonte

Adam C. Labonte is a scholar working on Rheumatology, Immunology and Oncology, having authored 10 papers that have together received 684 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (6 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Immunology (374 citations), Rheumatology (189 citations) and Infectious Diseases (100 citations). Adam C. Labonte has collaborated with scholars based in United States. Frequent co-authors include Young S. Hahn, Annie‐Carole Tosello‐Trampont, Amrie C. Grammer, Peter E. Lipsky, Michelle D. Catalina, Katherine A. Owen, Prathyusha Bachali, Robert Robl, Nicholas Geraci and Kathryn M. Kingsmore. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026